Browse by alphabet

0 1 2 3 4 5 6 7 8 9
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z

Common search terms

- chromosome 18
- golgi´s cell
- semi-daonil
- otic ganglion
- lasik clinics
- peptostreptococcus micros
- palatine glands
- analgesics
- oncologist
- epstein´s pearls
- parasitic cyst
- smooth chorion
- probiotics and prebiotics
- dominant gene
- yellow fever virus
- temporal apophysis
- achilles´ tendon
- condylar guide
- general anaesthetic
- olopatadine
 
Pages for 5-fu
>
 

Chemo Combination Therapy

Learn About A Proven Oral Chemo & Its Use In Combination Therapy. (Sponsored Link)
http://www.XELODA.com/
>
 

Colon Cancer Chemotherapy

Eloxatin – part of a systemic regimen for advanced cancer stages (Sponsored Link)
http://www.Eloxatin.com/
>
 

Is 5 Fu - Cheap Prices

Get the Best Value on Is 5 Fu. Find Nextag Sellers' Lowest Price. (Sponsored Link)
http://www.NexTag.co.uk
1
 

5-FU and Mitomycin C

... What are 5-FU and Mitomycin C? 5-FU (short for 5-Fluorouracil) and Mitomycin C is a type of chemotherapy regime that is used to treat some types of cancer. This fact sheet describes...
http://www.doctoronline.nhs.uk/masterwebsite1Asp/targetpages/specialts/chemo/5fumitmy.asp
2
 

5-Fluorouracil cream.DermNet NZ

DermNet NZ / Ad ... Topical 5-Fluorouracil 5% cream is often abbreviated to 5-FU. ... Afterwards rinse the finger thoroughly with water (or use a glove to apply the 5-FU). ... They are a necessary part...
http://www.dermnetnz.org/treatments/5-fluorouracil.html
3
 

CPT-11: Standard Treatment after 5-FU Failure?

Conrad Notes Index - ASCO Index / a timely medical meeting newsletter / CPT-11: STANDARD TREATMENT AFTER 5-FU FAILURE? ... The results support the conclusions reached by Van Cutsem that CPT-11 merits consideration as standard...
http://www.meds.com/conrad/asco98/cunningham.html
4
 

Figure 5

Resolution: standard / high / Figure 5. ... Protein (50 μg) was loaded for the controls and treated samples: (a) untreated cells; (b) Dox (0.1 μg/ml)→Pacl (0.1 μg/ml); (c) Dox (0.1 μg/ml)→Pacl (0.1 μg/ml)→48-h washout; (d) Dox (0.1...
http://breast-cancer-research.com/content/7/5/R681/figure/F5
5
 

IngentaConnect Treatment of Inflamed Hypertrophic Scars Using Intralesional 5-FU

Home / About Ingenta / Ingenta Labs / Ingenta Blog / Help / Check our FAQs ... The combination of 5-FU and Kenalog appeared to be more effective and less painful. ... conclusion. The use of 5-FU...
http://api.ingentaconnect.com/content/bsc/dsu/1999/00000025/00000003/art08165
6
 

Molecular Cancer |Full text |Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

Skip to main content / 15-Dec-2007 / Home | ... Levels of 5-FU incorporation into DNA were similar for the cell lines. ... Neither of them were altered in the parental cell line in response to 5-FU.
http://www.molecular-cancer.com/content/5/1/20
7
 

e-Prints Soton - Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperabl

... Median failure-free survival was 2.8 months for PVI 5-FU and 3.8 months for PVI 5-FU plus MMC (P = .14). Median survival was 5.1 months for PVI 5-FU and 6.5 months for PVI...
http://eprints.soton.ac.uk/26454/
8
 

Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.

Home / Pharmaceutical Reports / Pharmaceutical report sourcer ... Co-exposure to cerulenin enhanced 5-FU efficacy up to 20-, 81-, and 58-times in SK-Br3, MCF-7 and MDA-MB-231 cells, respectively. ... Of note, no antagonist...
http://www.leaddiscovery.co.uk/articles/17786362/
9
 

ISRCTN32414363 - Adjuvant X-ray & 5-Fluorouracil (5-FU) Infusion Study

Welcome / 03 January 2009 / Trial registration / Unique identification scheme / International databases / home | my details | / ISRCTN Register | / mRCT | / UKCTG | / links | / information | / press / Find trials / ISRCTN Register / tips on...
http://www.controlled-trials.com/ISRCTN32414363/
10
 

Glasgow ePrints Service - Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

GLASGOW ePRINTS SERVICE ... Capecitabine vs 5-FU/LV-associated adverse events required fewer medications and hospitalisations (cost savings £3653). ... Medical resource utilisation is significantly decreased with...
http://eprints.gla.ac.uk/2805/
 
 
 
1 | 2 | 3 | 4 | 5 | 6 | 7 | >
 
 
Helpful links | About Mediseek | Company | Privacy policy | Contact
Vertical portal made by

© 2007, Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH